Biodesix IncBDSX

NasdaqHealthcareServices-Medical Laboratories
Price (close)
$29.10
Market cap
$307.0M
P/E
—
Revenue (TTM)
$102.9M
Net income
-$27.8M
Dividend yield
—
1-year total return
263.5%
Net margin
-27.0%
Revenue growth
34.5%
Debt / equity
5.12x

What Biodesix Inc does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$45.6M$54.5M$38.2M$49.1M$71.3M$88.5M
Net income-$65.4M-$43.2M-$65.4M-$52.1M-$42.9M-$35.3M
Free cash flow-$23.3M-$30.5M-$48.3M-$45.8M-$51.9M-$23.5M

More on BDSX.

Figures from Biodesix Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.